A pharmacovigilance centre for monitoring and inspecting drugs is to be set up by December 2016.
According to a GINA press release, Director of the Government Analyst Food and Drug Department (GA-FDD), Marlan Cole, made this announcement on Tuesday at a Pharmacovigilance awareness workshop at Duke Lodge, where the GA-FDD in collaboration with the Pan American Health Organisation/World Health Organisation (PAHO/WHO) is creating sensitisation among health officials.
Pharmacovigilance, the release stated, is the practice of monitoring the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse reactions.
